Listening
Episodes
One search box across the whole catalog, titles and show notes alike. It earns its keep when you half-remember a case, a device or a name and want the conversation it came up in.
5,508 episodes · 33 shows
Audio unavailableThe Niche Episode 052 – AstraZeneca + Alexion, Lyell, Myovant, Foresee, GSK + Vir
M&A Speed Bumps, “Normal” IPO but not approach, two updates, and FDA gives nod to menstrual bleeding, prostate cancer, and COVID19 monoclonal antibodies.Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-052…
- Audio unavailable
The Niche Episode 051 – Oncology Trials, CRO Industry, Annovis, Janssen
Oncology on the move, an industry report looking at broader trends, good news in Alzheimer’s, and another niche oncology therapy approved. Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-051-1https://tinyurl.…
- Audio unavailable
The Niche Episode 050 – Apellis, Heron, AbbVie/Allergan + Soliton, Ginkgo, Caris
Two FDA approvals, cellulite and tattoos, Ginkgo pulls in $2.5B, and Caris massive growth equity for oncology testing. Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-50-1https://tinyurl.com/Niche-50-2https:/…
- Audio unavailable
The Niche Episode 049 – USA, Pfizer/BioNTech, Roivant, Science 37, Regeneron, Gyroscope
Critical intellectual property move by Biden-Harris, Pfizer goes for full approval, SPAC 1, SPAC 2, Regeneron drops big numbers, and an IPO gets punted. Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-049-1ht…
- Audio unavailable
The Niche Episode 048 – (Bonus) Interview with Dr. Kalali, co-chair of DTRA and founder of CNS Summit
Welcome to a monthly bonus episode. I sat down with Dr. Amir Kalali, the co-chair of the Decentralized Trials & Research Alliance (DTRA) – a clinical research coalition of the most influential companies in the field to talk about decent…
- Audio unavailable
The Niche Episode 047 – FDA, AstraZeneca, BioVie, Pfizer, Vaccitech, Werewolf
The FDA slaps wrists and takes names, Farxiga expands FDA approval, BioVie makes cash-light acquisition, Pfizer targets fungus, and one IPO down, another to go. Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche…
- Audio unavailable
The Niche Episode 046 – Vertex, CRISPR, Versant, GSK, Syneos + Medable, Velocity
Billion-dollar amendments, billion-dollar funds, GSK gets oncology nod from FDA, and two stories in clinical research. Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-046-1https://tinyurl.com/Niche-046-2https…
- Audio unavailable
The Niche Episode 045 – ThermoFisher + PPD, Trodelvy 2x, DiaSorin + Luminex, Merck, Novartis, and Vicarious
Massive acquisitions in the CRO space, Trodelvy 2x, diagnostic acquisitions, Merck closes COVID vaccine program, Xolair get’s self-injection nod, and tiny robots go for massive SPAC. Sponsorshttps://www.thescopemethod.comStory Referenceshtt…
- Audio unavailable
The Niche Episode 044 – Gilead, Bio-Techne + Asuragen, Vysioneer, Achilles
Gilead gets FDA approval in oncology, Bio-Techne acquires Asuragen, AI for tumor targeting, and Achilles completes $175M IPO. Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-044-1https://tinyurl.com/Niche-044…
- Audio unavailable
The Niche Episode 043 – Charles River, IQVIA, Agios, Alloy
Charles River acquires Retrogenix, IQVIA fully acquires Q2 Solutions, Agios sells $1.8B in oncology, and Alloy forges a $75M series C. Sponsorshttps://www.thescopemethod.com Story Referenceshttps://tinyurl.com/Niche-043-1https://tinyurl.com…
- Audio unavailable
The Niche Episode 042 – Interview with Dr. Benjamin Schwartz on Digital Healthcare (Bonus)
This is our March bonus episode. I sit down with Dr. Benjamin Schwartz an orthopedic surgeon and digital health expert. We talk digital integration, healthcare cost, and how you can get involved in the space. Sponsorshttps://www.thescopemet…
- Audio unavailable
The Niche Episode 041 – NeoGenomics + Trapelo, Medtronic, Gyroscope, Design
Mergers in precision oncology testing, Medtronic breakthrough valve replacement, Gyroscope raises capital for AMD, and small molecule genetic treatments get $240M IPO.Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com…
- Audio unavailable
The Niche Episode 040 – Janssen, Fujifilm, Agiliti + Northfield, and Aktis Oncology
A new MS therapeutic, Fujifilm picks CDMO facility site, consolidation in medical services, and a new oncology startup. Sponsorshttps://www.thescopemethod.com Story Referenceshttps://tinyurl.com/Niche-040-1https://tinyurl.com/Niche-040-2htt…
- Audio unavailable
The Niche Episode 039 – Kintor, AVEO, Takeda + Maverick, AgomAb
92% reduction in COVID mortality, AVEO gets FDA approval, Takeda acquires Maverick and targets emerging markets, and AgomAb raises $74M Series B for regenerative medicine. Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyur…
- Audio unavailable
The Niche Episode 038 – Amgen, Five Prime, KemPharm, Colfax
Amgen nabs Five Prime Therapeutics in $1.9B deal, KemPharm ligates their way out of debt with ADHD, three failed COVID19 pipelines, and Colfax follows 2019 merger with corporate split. Sponsorshttps://www.thescopemethod.comStory Referencesh…
- Audio unavailable
The Niche Episode 037 – (Bonus) Interview with Dr. Mitrani, CSO at Organicell
I sit down with Dr. Mitrani, the Chief Scientific Officer for Organicell, a clinical stage biopharma company focused on regenerative medicine. Their leading product, Zofin is currently in early clinical trials for the treatment of COVID19. …
- Audio unavailable
The Niche Episode 036 – PRA + ICON, J&J + FDA, Oncopeptides, Roivant, Merck
PRA acquired by Icon, Johnson & Johnson’s vaccine approved, Oncopeptides’ earns FDA approval, Roivant acquires Silicone Therapeutics, and Merck acquires Pandion.Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/n…
- Audio unavailable
The Niche Episode 035 – Eli Lilly, Charles River, Adjuvant Capital, Everlywell, Abbott
Eli Lilly bets on RIPK1, Charles River spends $875M on cell and gene therapy, Adjuvant Capital gets who’s who in backing, you can now buy an at-home COVID19 testing kit whenever you want, and Abbott does it again for the 389th time. Sponsor…
- Audio unavailable
The Niche Episode 034 – Genentech, GSK, BMS, Cassava, Sanofi, Hyperfine
Genentech’s next tech, GSK divests to invest, Bristol Myers Squibb checks oncology, Cassava Sciences raises capital, Libtayo gets expanded FDA approval, and Hyperfine turns on hyperdrive. Sponsorshttps://www.thescopemethod.comStory Referenc…
- Audio unavailable
The Niche Episode 033 – Merck 3x, Parexel, NeoGenomics, 23andMe, Revolution Medicine, and Sana
Two Mercks - three stories, Paraxel gets genomes, Genomes get Money, and 2021 is the year of the upsized public offering. Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-33-Merck1https://tinyurl.com/Niche-33-…
- Audio unavailable
The Niche Episode 032 – Biogen, Aurinia, Senseonics, Novavax, and J&J
Biogen gets punted but it’s good, lupus breakthroughs, Senseonics raises capital, and Novavax and Johnson & Johnson… and Janssen.Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-032-1https://tinyurl.com/Ni…
- Audio unavailable
The Niche Episode 031 - (Bonus) Interview with John Reites CEO of Thread Research
This is our January interview bonus. I sit down with John Reites, founder and CEO of Thread Research to discuss eCOA, decentralized clinical trials past, present, and future, and how you can think about a decentralized approach to your proj…
- Audio unavailable
The Niche Episode 030 – Thermo Fisher Scientific, Boston Scientific, Verve, and Vera
Thermo Fisher Scientific spends a billion, Boston Scientific also spends a billion and gets FDA approval, Verve pulls $94 million for CRISPR in humans, and Vera raises $80 million for Berger’s diseaseSponsorshttps://www.thescopemethod.comSt…
- Audio unavailable
The Niche Episode 029 – 100m, EvoQ + Amgen, Merck, Noctrix, Delfi
100 million vaccines, EvoQ’s NanoDisk, Merck gets FDA priority, and startups in wearables, startups in diagnostics. Sponsorshttps://www.thescopemethod.com Story Referenceshttps://tinyurl.com/Niche029-1https://tinyurl.com/Niche029-2https://t…